After being diagnosed with stage 3C breast cancer, retired teacher Janet Fuller sought a treatment approach that aligned with ...

Graced with good weather and even better science, the 2026 International Invasive Lobular Carcinoma (ILC) Symposium, held ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

Despite a tumultuous year of changes and proposed changes to the way the federal government invests in scientific research, the director of the National Cancer Institute, Anthony Letai, MD, PhD, sees ...

T-cell acute lymphoblastic leukemia (ALL) is a less common subtype of acute lymphoblastic leukemia. It happens more often in adults than in children. T-cell ALL starts in immature cells that would ...

This event is open only to students and alumni of the University of Virginia. The Virtual Fall Job & Internship Fair connects students and employers across the biotech, science, healthcare, and life ...

Dr. Jeremy Hollis talks with John Higgins about the two molecular mysteries that he solved on the way to earning his ...

The 2026 Quality and Cost Report provides updated findings for quality metrics and associated costs in cancer care. The intended use of this report, and the goal of community reporting, is to examine ...

Martell “Tell” Stokes recently joined Fred Hutch’s proton therapy facility from UW Medicine, where he was a radiology scheduler for six years. Although he learned a lot and enjoyed the work, he was ...

Fred Hutch was founded on the bold innovations and pioneering research that led our earliest clinicians to discover bone marrow transplantation as a cure for leukemia. Building on this Nobel ...

IN for the Hutch is Innovators Network's (IN) annual celebration of science, where next-generation doers come together to ignite big ideas with the potential to end cancer and related diseases in our ...

Fred Hutch scientists conduct research on and develop therapies for many cancers — including blood cancers and solid tumors — as well as for HIV and other nonmalignant diseases. Our scientists study ...